What Researchers Did
Researchers administered a neuropsychological screening battery to 35 individuals exposed to low-level carbon monoxide and 20 control subjects, testing them before and after hyperbaric oxygen therapy for the exposed group.
What They Found
Both the 35 CO-exposed subjects and 20 control subjects showed significant performance improvement when completing the neuropsychological tests for the second time, indicating a practice effect. Additionally, baseline test scores were not significantly different between the CO-exposed and control groups. Despite these findings, all CO-exposed victims reported immediate subjective improvement of their symptoms after hyperbaric oxygen therapy.
What This Means for Canadian Patients
Canadian patients experiencing subtle symptoms of low-level carbon monoxide poisoning, such as memory loss or concentration issues, may not find objective confirmation through neuropsychological tests. However, if treated with hyperbaric oxygen, they might still experience subjective relief from their symptoms, even if tests do not show objective improvement.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's findings are limited by the neuropsychological test's inability to differentiate between CO-exposed and control groups or objectively measure treatment efficacy.